BOSTON, June 01, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for ...

Students can explore various such platforms to make learning fun. Several educational platforms also offer skill-based ...

At the NIH, political appointees exercise extensive control over scientific communication, and research on health ...

The National Weather Service has placed a level 2 risk, or at least a 15% chance, of flooding rainfall on the Austin area ...

Grünenthal announced today that the company successfully concluded a Phase I trial evaluating the safety and tolerability of its ...

The University of Wyoming’s Department of Molecular Biology will host an upcoming seminar series featuring world-renowned biologist Dr. Alejandro Sánchez Alvarado, who is president, chief scientific ...

Ritesh is a key addition to Kyverna as we prepare for commercialization and enter our next phase of growth,” said Warner Biddle, Chief Executive Officer of Kyverna. “Ritesh’s experience in corporate ...

Researchers developed an AI-driven pipeline to identify novel antibiotic compounds against drug-resistant gonorrhea. By ...

Most house mice in northeastern cities now carry genes that help them survive common rodent poisons, scientists found.

The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain. In a Phase I trial, the ...

Northern Nigeria is angry. This anger is not strictly borne from the unremitting, horrific spillage of blood on its soil.